Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Target Price at $20.40
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has been given an average recommendation of “Buy” by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock […]
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has been given an average recommendation of “Buy” by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock […]
